WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , Scientific Journal Impact Factor (SJIF) , IFSIJ Measure of Journal Quality , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Academia , Scope Database , Research Publication Rating and Indexing , Doi-Digital Online Identifier , ISSN National Centre , Zenodo Indexing , International CODEN Service, USA , 

ISSN 2457-0400

Impact Factor  :  7.675

WJAHR Citation

  All Since 2020
 Citation  105  60
 h-index  4  4
 i10-index  3  2

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • WJAHR: New Impact Factor

    WJAHR Impact Factor has been Increased from  5.464 to 7.675 for Year 2026.

  • WJAHR: AUGUST ISSUE PUBLISHED

    AUGUST 2026 Issue has been successfully launched on AUGUST 2026.

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR August 2026 Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

Best Article Awards

World Journal of Advance Healthcare Research (WJAHR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

INVESTIGATION OF THE RESVERATROL EFFECT ON IL-6 RECEPTOR GENE EXPRESSION LEVEL IN ACUTE MYELOID LEUKEMIA CELL

Bara al-Jaburi*, Hadeel Hameed Dawood, Dalya Farpoq Najeeb

ABSTRACT

Resveratrol has been extensively investigated as a natural compound with promoising anticancer properties. the present study evaluated whether resveratrol modulates IL-6R gene expression in the AML derived KG-1 a cell line. cells were exposed to different concentrations of resveratrol for varying incubation period and cytotoxicity was determined using MTT assay to detect the inhibitory concentration (IC50). RNA was isolated from treated cells, and IL-6R expression was evaluated using RT*qPCR. The expression of IL-6R was quantified using real-time reverse transcription polymerase chain reaction (RT-PCR). The Results appeared the resveratrol significantly reduced KG1-a cell viability in a dose- and time-dependent manner, with IC50 values ranging from 30 to 40 µM. RNA integrity was confirmed by the presence of distinct 28S and 18S rRNA bands. Gene expression analysis demonstrated a significant downregulation of IL-6R mRNA levels following treatment with the IC50 concentration of resveratrol for 72 hours (P < 0.001), showing an approximately 1.5-fold decrease compared with untreated controls. This study conclude that Resveratrol exhibited significant anti-leukemic activity against KG1-a cells by reducing cell viability and suppressing IL-6R gene expression.

[Full Text Article] [Download Certificate]